Chemokines are a large family of small secreted proteins that have fundamental roles in
organ development, normal physiology, and immune responses upon binding to their …

Simple Summary Chemokine signaling is crucial for tumorigenesis, proliferation,
angiogenesis, tumor progression and metastasis in glioblastoma. Furthermore, chemokines …

Background Glioblastoma multiforme (GBM) is one of the lethal malignant tumors of the
central nervous system. Despite advances made in understanding this complex disease …

Glioblastoma (GBM) is a highly aggressive brain tumor associated with limited therapeutic
options and a poor prognosis. CXCR3, a chemokine receptor, serves dual autocrine …

The incidence of gliomas is increasing. Although great progress in glioma treatment has
been made, the clinical outcome remains unsatisfactory. Chemokine (C‐C motif) ligand 2 …

Introduction Glioblastoma is the most aggressive brain tumor, typically associated with poor
prognosis. Its treatment is challenging due to the peculiar glioblastoma cell biology and its …

Background: Despite intense interest in molecular characterization and searches for novel
therapeutic targets, the glioblastoma remains a formidable clinical challenge. Among many …

Introduction: Malignant gliomas are the most common and aggressive primary brain tumor
with current available therapies increasing median survival to a modest 20 months. Multiple …

Objective: To investigate the interactions between select flavonoids (Luteolin, Quercetin,
Apigenin, Kaempferol, and Amorphine) and the CXCR3 receptor, evaluating their potential …

Glioblastoma is the most common malignant tumor in the central nervous system and its
occurrence and development is involved in various molecular abnormalities. CXC …